SCHEMBL7765340

SCHEMBL7765340

C=CC(N)NC(=O)c1ccc2ccccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 1/20 0.53
EGFR P00533 1/20 0.53
TP53 P04637 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
PKM P14618 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
ALOX12 P18054 1/20 0.53
JAK1 P23458 1/20 0.53
MAPK1 P28482 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
PIN1 Q13526 5/20 0.49
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7532641 0.95 KDM4E (0.47) KDM4EMEN1KMT2AALDH1A1EGFR
SCHEMBL7411194 0.82 PTPRC (0.47) MEN1KMT2AALDH1A1MAPTPKM
SCHEMBL4442412 0.80 SLC1A2 (0.54) KMT2AALDH1A1MAPTHPGDALOX15
SCHEMBL7566579 0.79 TTR (0.51) MEN1KMT2AALDH1A1MAPTPKM
SCHEMBL27568636 0.78 CES2 (0.53) KDM4EMEN1KMT2AALDH1A1EGFR
SCHEMBL31030764 0.76 MEN1 (0.61) KDM4EMEN1KMT2AALDH1A1EGFR
SCHEMBL7477122 0.76 NPC1 (0.56) KDM4EMEN1KMT2AALDH1A1PIN1
SCHEMBL9595514 0.75 PIN1 (0.49) KDM4EMEN1KMT2AALDH1A1EGFR
SCHEMBL8416550 0.75 SLC1A2 (0.69) PIN1CES2CES1DEGS1NR1H4
SCHEMBL1149678 0.73 NPC1 (0.62) KDM4EMEN1KMT2AALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0873329-B1 NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-06-06 EP disclosed
EP-1081142-A2 Novel N-Aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands NEUROGEN CORPORATION (US) 2001-03-07 EP disclosed
US-6015900-A FOR TREATMENT OF PSYCHOTIC OR CENTRAL NERVOUS SYSTEM DISORDERS NEUROGEN CORPORATION (US) 2000-01-18 US disclosed
US-5932734-A HIGH AFFINITY AND SELECTIVITY IN BINDING TO THE D3 RECEPTOR SUBTYPE; PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION (US) 1999-08-03 US disclosed
EP-0873329-A1 NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1998-10-28 EP disclosed
US-5659033-A PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION (US) 1997-08-19 US disclosed
WO-1997010229-A1 NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1997-03-20 WO disclosed